According to fierce biotech.com, glaxosmithsklins's (GSK) cervical cancer vaccine cervarix has been approved for market in the USA.The vaccine is said to be the most effective in preventing cervical cancer due to HPV.This is good news for young women, who can now be protected from cervical cancer......
Reference
http://www.fiercebiotech.com/story/glaxo-finally-wins-fda-approval-cervarix/2009-10-19
No comments:
Post a Comment